Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the period ending February 21, 2018. The report addresses a corporate governance matter regarding a proposed Special Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements.
Material Changes
On February 21, 2018, the Company determined to withdraw a proposal to grant stock options that was scheduled for a Special Meeting of Shareholders on February 22, 2018. This withdrawal occurred because the intended grantee waived their right to receive the options. Consequently, the Special Meeting of Shareholders was cancelled.
Guidance, Outlook, and Risks
The filing contains no management commentary on future guidance, outlook, or general business risks. The only contingency noted is the cancellation of the shareholder meeting due to the grantee's waiver.
Key Facts for Investors
- The Special Meeting of Shareholders scheduled for February 22, 2018, has been cancelled.
- The cancellation resulted from the withdrawal of a stock option grant proposal.
- The withdrawal was initiated because the grantee waived their right to the options.
- No financial performance data is included in this specific filing.